Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis

Quentin Moyon,Félicien Triboulet,Jean Reuter,Guillaume Lebreton,Amandine Dorget,Marylou Para,Juliette Chommeloux,Jules Stern,Marc Pineton de Chambrun,Guillaume Hékimian,Charles-Edouard Luyt,Alain Combes,Romain Sonneville,Matthieu Schmidt,Schmidt, Matthieu
DOI: https://doi.org/10.1007/s00134-024-07354-2
IF: 38.9
2024-03-05
Intensive Care Medicine
Abstract:The outcomes of immunocompromised patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) are seldom documented, making ECMO candidacy decisions challenging. This study aims (1) to report outcomes of immunocompromised patients treated with VA-ECMO, (2) to identify pre-ECMO predictors of 90-day mortality, (3) to assess the impact of immunodepression on 90-day mortality, and (4) to describe the main ECMO-related complications.
critical care medicine
What problem does this paper attempt to address?